0001415889-19-000009.txt : 20190102 0001415889-19-000009.hdr.sgml : 20190102 20190102175532 ACCESSION NUMBER: 0001415889-19-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181228 FILED AS OF DATE: 20190102 DATE AS OF CHANGE: 20190102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Riddell Alastair CENTRAL INDEX KEY: 0001681349 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 19502926 MAIL ADDRESS: STREET 1: C/OAZURRX BIOPHARMA,INC.760 PARKSIDE AVE STREET 2: DOWNSTATE BIOTECHNOLOGY INCUBATOR,STE217 CITY: BROOKLY STATE: NY ZIP: 11226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4 1 form4-01022019_020116.xml X0306 4 2018-12-28 0001604191 AzurRx BioPharma, Inc. AZRX 0001681349 Riddell Alastair SUITE 304 BROOKLYN NY 11226 true false false false Common Stock 2018-12-28 4 A 0 7500 1.29 A 70000 D Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018. /s/ Maged Shenouda, Attorney-in-Fact 2019-01-02